Open access · CC-BY
via OpenAlex
The genetics of Alzheimer's disease
Eva Bagyinszky, Young Chul Youn, Seong Soo A. An, SangYun Kim
Clinical Interventions in Aging · 2014 · ▲ 173 citations
Abstract
Alzheimer's disease (AD) is a complex and heterogeneous neurodegenerative disorder, classified as either early onset (under 65 years of age), or late onset (over 65 years of age). Three main genes are involved in early onset AD: amyloid precursor protein (APP), presenilin 1 (PSEN1), and presenilin 2 (PSEN2). The apolipoprotein E (APOE) E4 allele has been found to be a main risk factor for late-onset Alzheimer's disease. Additionally, genome-wide association studies (GWASs) have identified several genes that might be potential risk factors for AD, including clusterin (CLU), complement receptor 1 (CR1), phosphatidylinositol binding clathrin assembly protein (PICALM), and sortilin-related receptor (SORL1). Recent studies have discovered additional novel genes that might be involved in late-onset AD, such as triggering receptor expressed on myeloid cells 2 (TREM2) and cluster of differentiation 33 (CD33). Identification of new AD-related genes is important for better understanding of the pathomechanisms leading to neurodegeneration. Since the differential diagnoses of neurodegenerative disorders are difficult, especially in the early stages, genetic testing is essential for diagnostic processes. Next-generation sequencing studies have been successfully used for detecting mutations, monitoring the epigenetic changes, and analyzing transcriptomes. These studies may be a promising approach toward understanding the complete genetic mechanisms of diverse genetic disorders such as AD.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2147/cia.s51571
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Bagyinszky, E., Youn, Y.C., An, S.S.A., & Kim, S. (2014). The genetics of Alzheimer's disease. <em>Clinical Interventions in Aging</em>. https://doi.org/10.2147/cia.s51571
Vancouver
Bagyinszky E, Youn YC, An SSA, Kim S. The genetics of Alzheimer's disease. Clinical Interventions in Aging. 2014. doi:10.2147/cia.s51571.
BibTeX
@article{eva2014Thegen,
title = {The genetics of Alzheimer's disease},
author = {Eva Bagyinszky and Young Chul Youn and Seong Soo A. An and SangYun Kim},
journal = {Clinical Interventions in Aging},
year = {2014},
doi = {10.2147/cia.s51571},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Molecular Psychiatry 2021
Open access · CC-BY
The Amyloid-β Pathway in Alzheimer’s Disease
Journal of Cachexia Sarcopenia and Muscle 2015
Open access · CC-BY
Behavioural changes are a major contributing factor in the reduction of sarcopenia in caloric-restricted ageing mice
BMC Geriatrics 2019
Open access · CC-BY
A new age-related cutoff of medial temporal atrophy scale on MRI improving the diagnostic accuracy of neurodegeneration due to Alzheimer’s disease in a Chinese population
Nature Reviews Genetics 2016
Preprint · OA
Coming of age: ten years of next-generation sequencing technologies
2022
Open access · CC0
Investigating the temporal pattern of neuroimaging-based brain age estimation as a biomarker for Alzheimer's disease related neurodegeneration
Dementia & Neuropsychologia 2016
Open access · CC-BY